Spero Therapeutics, Inc.

NASDAQ:SPRO

1.34 (USD) • At close September 18, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q3
Omzet 6.0174.20471.82725.4730.7880.7446.3021.0820.8960.2472.7443.0645.1487.31.9073.9951.7270.1690.6960.1722.1563.8071.6920.6580.4631.1530.9930.5970.2490.140.3350
Kosten van de omzet 0.002-5.0630.0380.1089.518.9790.3610.4858.17300000000000000000000000
Brutowinst 6.0159.26771.78925.365-8.722-8.23945.9410.597-7.2770.2472.7443.0645.1487.31.9073.9951.7270.1690.6960.1722.1563.8071.6920.6580.4631.1530.9930.5970.2490.140.3350
Brutowinstmarge 12.2040.9990.996-11.069-11.1340.9920.552-8.12211111111111111111111110
Onderzoek- en ontwikkelingskosten 23.72317.33216.5216.3939.518.97915.0897.368.17316.97117.22514.43614.46118.40413.20517.70615.65620.43625.72818.49512.0269.5269.1278.4597.3748.92512.5036.917.4575.9996.9276.005
Algemene en administratieve kosten 5.5335.9176.4335.7086.0967.3176.4956.6328.05115.30513.02111.1529.2298.2997.4985.3094.5474.0863.7854.1333.7823.8883.6493.1343.063.0442.493.6532.9571.742.2181.909
Verkoop- en marketingkosten 00000000000000000000000000000000
Verkoop-, algemene en administratieve kosten 5.5335.9176.4335.7086.0967.3176.4956.6328.05115.30513.02111.1529.2298.2997.4985.3094.5474.0863.7854.1333.7823.8883.6493.1343.063.0442.493.6532.9571.742.2181.909
Overige kosten 0.001-0.0140.0035.306-0.006-1.329-1.087-0.924-0.01-1.822-0.078-0.087-0.112-0.1180.2110.0550.889-0.6740.6740000.485000-0.7700000
Bedrijfskosten 29.25623.24922.95327.40713.67814.96720.49713.06815.12730.45430.24625.58823.6926.70320.70323.01520.20322.9926.57918.15715.8089.50311.08410.9359.97110.816149.96610.1657.5999.1457.914
Bedrijfsresultaat -23.241-19.04548.836-1.934-12.89-14.22725.924-11.834-26.08-30.207-27.502-22.524-18.542-19.403-18.796-19.02-18.476-22.821-25.883-17.985-13.652-5.696-11.084-10.935-9.971-10.816-14-9.966-10.165-7.599-8.81-7.914
Bedrijfsresultaat ratio -3.863-4.530.68-0.076-16.358-19.2260.56-10.937-29.107-122.296-10.023-7.351-3.602-2.658-9.856-4.761-10.698-135.036-37.188-104.564-6.332-1.496-6.551-16.619-21.536-9.381-14.099-16.693-40.823-54.279-26.2990
Totaal overige inkomsten en kosten netto 5.3796.3762.7430.94-0.0060.9610.8470.159-14.445-2.6220.126-0.087-0.112-0.1180.2110.0550.889-0.6740.6740.2680.5020.6240.4850.4720.0150.172-0.77-0.0020.351.1990.617-0.004
Inkomen voor belasting -17.862-12.66951.579-0.994-11.914-13.26626.771-11.675-28.682-32.829-29.24-22.521-18.572-19.423-18.585-18.936-17.501-23.258-25.209-17.717-13.15-5.072-10.599-10.463-9.956-10.644-14.77-9.844-9.763-6.411-8.197-7.918
Inkomen voor belasting ratio -2.969-3.0140.718-0.039-15.119-17.9270.578-10.79-32.011-132.911-10.656-7.35-3.608-2.661-9.746-4.74-10.134-137.621-36.22-103.006-6.099-1.332-6.264-15.901-21.503-9.232-14.874-16.489-39.209-45.793-24.4690
Belastingkosten 0-0.0920.387-2.211-0.006-0.9610.002-0.1590.1072.6221.94-0.09-0.082-0.098-0.191-0.029-0.086-0.2370.111000-0.1390001.137-0.13-0.996-0.524-1.599-1.598
Nettowinst -17.862-12.66951.191-3.205-11.914-12.30526.771-11.516-28.682-35.451-29.24-22.521-18.572-19.423-18.585-18.936-17.501-23.258-25.209-17.717-13.15-5.072-10.599-10.463-9.956-10.644-14.77-9.836-9.169-5.876-7.211-6.316
Nettowinstmarge -2.969-3.0140.713-0.126-15.119-16.6280.578-10.643-32.011-143.526-10.656-7.35-3.608-2.661-9.746-4.74-10.134-137.621-36.22-103.006-6.099-1.332-6.264-15.901-21.503-9.232-14.874-16.476-36.823-41.971-21.5250
WPA (Winst Per Aandeel) -0.33-0.240.97-0.061-0.23-0.230.55-0.32-0.87-1.09-0.91-0.7-0.63-0.66-0.68-0.86-0.85-1.19-1.32-0.95-0.74-0.29-0.6-0.6-0.69-0.74-1.59-0.73-1.39-0.89-1.09-0.96
Verwaterde WPA -0.33-0.240.96-0.061-0.23-0.230.55-0.32-0.87-1.09-0.91-0.7-0.63-0.66-0.68-0.86-0.85-1.19-1.32-0.95-0.74-0.29-0.6-0.6-0.69-0.74-1.59-0.73-1.39-0.89-1.09-0.96
EBITDA -23.239-19.04548.874-1.934-11.806-13.15325.79-11.544-13.836-29.959-27.156-22.376-18.394-19.244-18.796-18.829-18.286-22.632-25.883-17.496-13.464-5.512-11.084-10.854-9.877-10.721-14-9.87-10.432-7.512-9.342-7.836
EBITDA ratio -3.862-4.530.68-0.076-14.982-17.7740.557-10.669-15.442-121.291-9.897-7.303-3.573-2.636-9.856-4.713-10.588-133.917-37.188-101.721-6.245-1.448-6.551-16.495-21.333-9.298-14.099-16.533-41.896-53.657-27.8870